Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases

Author(s): Somaraju R. Kumar, Chetan H. Mehta, Usha Y. Nayak*

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 6 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Medication and patient adherence are the two main aspects of any successful treatment of chronic disease. Even though diseases and its treatment existed for several hundred years, the treatment optimization for a given patient is still a researcher question for scientists. There are differences in treatment duration, prognostic signs and symptoms between patient to patient. Hence, designing ideal formulation to suit individual patient is a challenging task. The conventional formulations like oral solids and liquids gives a partial or incomplete treatment because the patient needs to follow the daily pills for a longer time. In such cases, the long-acting formulations will have better patient compliances as drug will be released for a longer duration. Many such approaches are under the clinical investigation. The favorable pharmacokinetic and pharmacodynamic relationships, will be promising option for the treatment of chronic diseases. In this review, we have highlighted the importance of long-acting formulations in the treatment of chronic diseases and the advent of newer formulation technologies.

Keywords: Long-acting formulations, prescription adherence, chronic diseases, microspheres, implants, organogels.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 27
ISSUE: 6
Year: 2021
Published on: 14 March, 2021
Page: [876 - 889]
Pages: 14
DOI: 10.2174/1381612826666200707122012
Price: $65

Article Metrics

PDF: 83